CIK 0001676725
- Large accelerated filer
IDEAYA Biosciences, Inc.
Sign in to watch- Ticker
- IDYA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474268251
- Phone
- +1 650-443-6209
- Business address
- 5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $985,397
- in 1 filing, $985K under 10b5-1 plans
Net −$985,397. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-10-04 | Dillon Michael P. SVP, Chief Scientific Officer | Option exercise | +1,500 | $11.08 | $17K | 80,289 |
| 2021-10-04 | Dillon Michael P. SVP, Chief Scientific Officer | Sale | −500 | $25.85 | $13K | 79,789 |
| 2021-10-04 | Dillon Michael P. SVP, Chief Scientific Officer | Sale | −1,000 | $26.62 | $27K | 78,789 |
| 2021-10-04 | Dillon Michael P. SVP, Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −1,500 | 23,437 | ||
| 2021-09-08 | Dillon Michael P. SVP, Chief Scientific Officer | Option exercise | +7,071 | $4.31 | $30K | 85,860 |
| 2021-09-08 | Dillon Michael P. SVP, Chief Scientific Officer | Option exercise | +4,313 | $11.08 | $48K | 90,173 |
| 2021-09-08 | Dillon Michael P. SVP, Chief Scientific Officer | Sale | −11,184 | $27.41 | $307K | 78,989 |
| 2021-09-08 | Dillon Michael P. SVP, Chief Scientific Officer | Sale | −200 | $27.67 | $6K | 78,789 |
| 2021-09-08 | Dillon Michael P. SVP, Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −7,071 | 59,048 | ||
| 2021-09-08 | Dillon Michael P. SVP, Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −4,313 | 24,937 | ||
| 2021-09-07 | Dillon Michael P. SVP, Chief Scientific Officer | Option exercise | +116 | $4.31 | $500 | 78,905 |
| 2021-09-07 | Dillon Michael P. SVP, Chief Scientific Officer | Sale | −116 | $27.46 | $3K | 78,789 |
| 2021-09-07 | Dillon Michael P. SVP, Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −116 | 66,119 | ||
| 2021-09-02 | Dillon Michael P. SVP, Chief Scientific Officer | Sale | −10,000 | $25.09 | $251K | 78,789 |
| 2021-08-09 | Dillon Michael P. SVP, Chief Scientific Officer | Option exercise | +1,500 | $4.31 | $6K | 100,289 |
| 2021-08-09 | Dillon Michael P. SVP, Chief Scientific Officer | Sale | −11,100 | $22.96 | $255K | 89,189 |
| 2021-08-09 | Dillon Michael P. SVP, Chief Scientific Officer | Sale | −400 | $23.52 | $9K | 88,789 |
| 2021-08-09 | Dillon Michael P. SVP, Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −1,500 | 66,235 | ||
| 2021-07-27 | Dillon Michael P. SVP, Chief Scientific Officer | Option exercise | +5,000 | $6.92 | $35K | 103,789 |
| 2021-07-27 | Dillon Michael P. SVP, Chief Scientific Officer | Option exercise | +5,000 | $4.31 | $22K | 108,789 |
Page 1 of 3 · 46 trades